A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions

Phase 1 Completed 40 enrolled Boryung Pharmaceutical Co., Ltd

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical study is to evaluate the pharmacokinetics and safety between single oral administration of BR3006 and co-administration of BR3006A, BR3006B and BR3006C in healthy adult volunteers under fed conditions

Timeline

Start: 2024-12-05
Primary completion: 2025-01-12
Completion: 2025-01-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BR3006	Unknown	—	Oral
Comparator	BR3006A	Unknown	—	Oral
Comparator	BR3006B	Unknown	—	Oral
Comparator	BR3006C	Unknown	—	Oral

A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions

Summary

Timeline

Drugs

Indications